Posterior reversible encephalopathy syndrome following infliximab infusion.
Zamvar
Veena
V
Department of Paediatric Gastroenterology, The Children's Centre, The General Infirmary at Leeds, Leeds, UK. veenazamvar@hotmail.com
Sugarman
Ian D
ID
Tawfik
Rihab F
RF
Macmullen-Price
Jeremy
J
Puntis
John W L
JW
D015746:Abdominal Pain; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001379:Azathioprine / Q000627:therapeutic use; D001927:Brain Diseases / Q000139:chemically induced* / Q000175:diagnosis; D003082:Colectomy; D003113:Colonoscopy; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D003967:Diarrhea; D005401:Fissure in Ano / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007081:Ileostomy; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D012640:Seizures / Q000139:chemically induced; D013577:Syndrome; D014786:Vision Disorders / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D011239:Prednisolone; D000069285:Infliximab; D001379:Azathioprine